Inicio > Cuidados Intensivos. Cuidados Críticos. > Diabetes Mellitus y estrés Oxidativo > Página 8

Diabetes Mellitus y estrés Oxidativo

REFERENCIAS BIBLIOGRÁFICAS:

1. Comité de Expertos de la OMS en Diabetes Sacarina, 2do Informe. Serie de Informes Técnicos 646, Ginebra, Suiza, 2000.

2. Williams R. Diabetes Mellitus. Tratado de Endocrinología, 4ta Edición. Salvat. Editores. Barcelona. 2003:703.

3. Díaz DO. Prevalencia de la Diabetes en un sector Urbano-Rural, Artemisa. Tesis de Especialista de I grado en Medicina General Integral. La Habana: INHEM, 2004:25.

4. Dum F. Hiperlipemia and Diabetes, Med Clin North Am. 77:2005, 1992:254.

5. UHA. Structure Study of the effect of Insulin dosage. On the myocardium of spontaneously Diabetic RB rate. Can J. PhysiologyPharmacol, 1998:65.

6. Mc Millan D. Effects of Insulin of physical factors: Atherosclerosis in Diabetes Mellitus. Metab Clin Exp, 2004, 12/suppl: 70-7.

7. Borch-Johnson K, Kreinev S. Proteinuria: Value as predictor of cardiovascular mortality in insulin dependent Diabetes Mellitus. BMJ, 1997 294/6588:1651-54.

8. Nattock MB. Coronary Heart Disease and urinary albumin excretion rate type (non-Insulin-Dependent) Diabetes patients Diabetologia.2001:82-7.

9. Krolowski A. Magnitude and determinants of coronary artery disease in Juvenile on set, insulin dependent Diabetes Mellitus AMJ Cardiol.1998, 59/8:750 – 55.

10. Davis D. Risk factors for ischemia. Prospective study, Minnesota. Ann Neurol 2003, 27(3):319-27.

11. Garison RJ, WiIson P. Obesity. N.F-AM. J.MEA. 2003, 80(5):22-30.

12. Siitonen O. More exercise for the diabetes physical disease activity and prevention of ischemic heart. Ann Clin Res. 2003, 20(1-2):71-72.

13. McCowen KC, Malhotra A, Bistrian BR. Stress-induced hyperglycemia. Crit Care Clin 2001; 17: 107-24.

14. Kitabchi AE, Freire AX, Umpierrez GE. Evidence for strict inpatient blood glucose control: time to revise glycemic goals in hospitalized patients. Metabolism 2008; 57: 116-20.

15. Hirsch IB, McGill JB. Role of insulin in management of surgical patients with diabetes mellitus. Diabetes Care 1990; 13: 980-91.

16. Mizock BA. Blood glucose management during critical illness. RevEndocrMetabDisord 2003; 4: 187-94.

17. Dirección Nacional de Estadísticas y Centro Nacional de Información Médica. Anuario Estadístico de Salud en Cuba año 2003 [en línea] Disponible en: http://www.sld.cu/servicios/estadisticas/

18. Triana ME. La hiperglicemia y sus efectos tóxicos. Un concepto patogénico para la micro y macroangiopatía diabética. Rev Cubana AngiolCirVasc 2001;2(2):131-41.

19. Ceriello A, Hanefeld M, Leiter L, Monnier I, Moses A, Owens D, et al. Postpandrial glucose regulation and diabetic complications. Arch Intern Med 2004;164(19):2090-5.

20. Díaz M, Baiza LA, Ibáñez MA, Pascoe D, Guzmán AM, Kumate J. Aspectos moleculares del daño tisular inducido por la hiperglucemia crónica. GacMedMex 2004;140(4):437-47.

21. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001;414:813-20.

22. Menon V, Ram M, Dorn J, Armstrong D, Muti P, Freudenheim JL, et al. Oxidative stress and glucose levels in a population-based sample. Diabet Med 2004;21(12):1346-52.

23. Ford ES, Mokdad AH, Ajani UA, Liu S. Associations between concentrations of alpha and gamma- tocopherol on concentrations of glucose, glycosylated haemoglobin, insulin and C-peptide among US adults. Br J Nutr 2005;93(2):249-55.

24. Tsubouchi H, Inoguchi T, Inuo M, Kakimoto M, Sonta T, Sonoda N, et al. Sulfonylurea as well as elevated glucose levels stimulate reactive oxygen species production in the pancreatic beta cell line, MIN6- a role of NAD(P)H oxidase in beta-cells. BiochemBiophys Res Commun 2004;326(1):60-5.

25. Mohanty P Hamouda W, Garg R, Aljada A, Ghanim H, Dandona P. Glucose Challenge stimulates reactive oxygen species (ROS) generation by leucocytes. J Clin EndocrinolMetabol 2000;85(8):2970-3.

26. Kunisaki M, Umeda F, Yamauchi T, Masakado M, Nawata H. High glucose reduces specific binding for D-alpha-tocopherol in cultured endothelial aortic cells. Diabetes 1993;42(8):1138-46.

27. Ceriello A, Morocutti A, Mercuri F, Quagliaro L, Moro M, Damante G, et al. Defective intracellular antioxidant enzyme production in type 1 diabetic patients with nephropathy. Diabetes 2000;49(12):2170-7.

28. Clapés S, Armas D, Sánchez D, Lemani M, Márquez I, Valdés M, et al. Algunos indicadores de estrés oxidativo en niños diabéticos. Rev Cubana Farm 2002;26(2):203-5.

29. Salardi S, Zucchini S, Elleri D, Grossi G, Bargossi AM, Gualandi S, et al. High glucose levels induce an increase in membrane antioxidants, in terms of vitamin E and coenzyme Q10, in children and adolescents with type 1 diabetes. Diabetes Care 2004;27:630-1.

30. Smit AJ, Lutgers HL. The clinical relevance of advanced glycation end-products (AGE) and recent development in pharmaceutics to reduce AGE accumulation. CurrMedChem 2004;11(20):2767-84.

31. Díaz D. Óxido nítrico, mutagénesis y cáncer. Rev Cubana InvestBiomed 2004;23(3):184-9.

32. Xue-Liang D, Edelstein D, Rossetti L, Fantus IG, Golberg H, Ziyadeh F, et al. Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation. PNAS 2000;97(22):12222-6.